283 related articles for article (PubMed ID: 12778482)
1. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms.
Nicoll G; Avril T; Lock K; Furukawa K; Bovin N; Crocker PR
Eur J Immunol; 2003 Jun; 33(6):1642-8. PubMed ID: 12778482
[TBL] [Abstract][Full Text] [Related]
2. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells.
Kawasaki Y; Ito A; Withers DA; Taima T; Kakoi N; Saito S; Arai Y
Glycobiology; 2010 Nov; 20(11):1373-9. PubMed ID: 20663960
[TBL] [Abstract][Full Text] [Related]
4. Impact of polysialylated CD56 on natural killer cell cytotoxicity.
Moebius JM; Widera D; Schmitz J; Kaltschmidt C; Piechaczek C
BMC Immunol; 2007 Aug; 8():13. PubMed ID: 17683591
[TBL] [Abstract][Full Text] [Related]
5. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
Giardina SL; Anderson SK; Sayers TJ; Chambers WH; Palumbo GA; Young HA; Ortaldo JR
J Immunol; 1995 Jan; 154(1):80-7. PubMed ID: 7995961
[TBL] [Abstract][Full Text] [Related]
6. Altered ganglioside GD3 in HeLa cells might influence the cytotoxic abilities of NK cells.
Lee WC; Lee WL; Shyong WY; Yang LW; Ko MC; Yeh CC; Hsieh SL; Wang PH
Taiwan J Obstet Gynecol; 2012 Jun; 51(2):199-205. PubMed ID: 22795094
[TBL] [Abstract][Full Text] [Related]
7. Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression.
Zeng G; Li DD; Gao L; Birklé S; Bieberich E; Tokuda A; Yu RK
Biochemistry; 1999 Jul; 38(27):8762-9. PubMed ID: 10393551
[TBL] [Abstract][Full Text] [Related]
8. Human-specific expression of Siglec-6 in the placenta.
Brinkman-Van der Linden EC; Hurtado-Ziola N; Hayakawa T; Wiggleton L; Benirschke K; Varki A; Varki N
Glycobiology; 2007 Sep; 17(9):922-31. PubMed ID: 17580316
[TBL] [Abstract][Full Text] [Related]
9. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
10. The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.
Hashimoto N; Ito S; Tsuchida A; Bhuiyan RH; Okajima T; Yamamoto A; Furukawa K; Ohmi Y; Furukawa K
J Biol Chem; 2019 Jul; 294(28):10833-10845. PubMed ID: 31138648
[TBL] [Abstract][Full Text] [Related]
11. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
Hernández-Caselles T; Martínez-Esparza M; Pérez-Oliva AB; Quintanilla-Cecconi AM; García-Alonso A; Alvarez-López DM; García-Peñarrubia P
J Leukoc Biol; 2006 Jan; 79(1):46-58. PubMed ID: 16380601
[TBL] [Abstract][Full Text] [Related]
12. The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells.
Bergelson LD; Dyatlovitskaya EV; Klyuchareva TE; Kryukova EV; Lemenovskaya AF; Matveeva VA; Sinitsyna EV
Eur J Immunol; 1989 Nov; 19(11):1979-83. PubMed ID: 2598999
[TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
14. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.
Helfand SC; Dickerson EB; Munson KL; Padilla ML
Cancer Res; 1999 Jul; 59(13):3119-27. PubMed ID: 10397254
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a new sialic acid binding region that regulates Siglec-7.
Yamakawa N; Yasuda Y; Yoshimura A; Goshima A; Crocker PR; Vergoten G; Nishiura Y; Takahashi T; Hanashima S; Matsumoto K; Yamaguchi Y; Tanaka H; Kitajima K; Sato C
Sci Rep; 2020 May; 10(1):8647. PubMed ID: 32457377
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside binding pattern of CD33-related siglecs.
Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
18. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs.
Yamaji T; Mitsuki M; Teranishi T; Hashimoto Y
Glycobiology; 2005 Jul; 15(7):667-76. PubMed ID: 15703304
[TBL] [Abstract][Full Text] [Related]
19. Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers.
Miyazaki K; Ohmori K; Izawa M; Koike T; Kumamoto K; Furukawa K; Ando T; Kiso M; Yamaji T; Hashimoto Y; Suzuki A; Yoshida A; Takeuchi M; Kannagi R
Cancer Res; 2004 Jul; 64(13):4498-505. PubMed ID: 15231659
[TBL] [Abstract][Full Text] [Related]
20. Chemical Synthesis and Evaluation of a Disialic Acid-Containing Dextran Polymer as an Inhibitor for the Interaction between Siglec 7 and Its Ligand.
Yamaguchi S; Yoshimura A; Yasuda Y; Mori A; Tanaka H; Takahashi T; Kitajima K; Sato C
Chembiochem; 2017 Jul; 18(13):1194-1203. PubMed ID: 28374980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
